StockTipsArenaBeta

BUY Cohance Lifesciences Limited — Amit Shreeram Goel

BUYCohance Lifesciences Limited

byAmit Shreeram GoelHorizon: NA (inferred Swing (≤2wk))21 Aug 2026via NDTV Profit

Entry₹477.9Inferred
Target₹533
Total upside +11.53% (call closed)
Stop loss₹438-8.35% risk
At expiry₹459.13 Sept 2026, 3:30 pm
Expired-3.93%
Follow Amit Shreeram Goel for new calls(27% target hit, 37 closed calls)Get alertsWatch COHANCE for new buy/sell callsGet alertsSee 138 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 3 Sept 2026
2 supporting0 opposing
Supports the BUY call (2)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·20 Aug · 2w ago

Cohance Lifesciences narrows Q1FY27 loss to ₹241 crore, eyes H2 growth

NewsGoogle News·11 Aug · 3w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.